OneXpress™ Solution for Accelerating Development to Commercialisation

Published on: 

Sponsored Content

Catalent’s OneXpress™ solution combines phase-appropriate scale and technologies with expertise across diverse dose forms to simplify development and accelerate a programme towards commercialisation.

Catalent’s OneXpress is a single, integrated solution that provides the fastest pathway from clinical development to commercial manufacturing. By taking a proactive approach and assessing production considerations early in development, the solution can help reduce a programme’s risk and increase chances of success by working in parallel to address potential roadblocks and ensure robust processes from clinic to launch.

Using Catalent’s integrated global network of facilities, and streamlined programme management, the OneXpress solution combines the expertise at Catalent’s early-phase drug development centres of excellence in Nottingham, U.K., Somerset, New Jersey, and San Diego in the U.S., with the proven track-record of Catalent’s oral solid dose commercial manufacturing facilities.

Overseen by a dedicated programme manager from start to finish, OneXpress combines phase-appropriate technologies and proven expertise, with scalable end-to-end capabilities throughout an extensive supply network, to achieve optimal accelerated manufacturing solutions at every stage.